India's 8i Ventures hits first close on Fund II
8i Ventures, an India-based early-stage venture capital firm, has achieved a first close of approximately USD 25m on its second fund. The overall target is USD 50m.
Vikram Chachra, a general partner at 8i, told AVCJ earlier this year that all the LPs in Fund I – which closed on USD 15.5m in 2021 – would re-up for Fund II. The first close, originally slated for...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.